These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12871990)

  • 1. Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands.
    Montero-Hadjadje M; Pelletier G; Yon L; Li S; Guillemot J; Magoul R; Tillet Y; Vaudry H; Anouar Y
    J Histochem Cytochem; 2003 Aug; 51(8):1083-95. PubMed ID: 12871990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide.
    Anouar Y; Desmoucelles C; Yon L; Leprince J; Breault L; Gallo-Payet N; Vaudry H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2944-51. PubMed ID: 9709974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterisation and immunohistochemical localisation of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation.
    Boutahricht M; Guillemot J; Montero-Hadjadje M; Bellafqih S; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
    J Neuroendocrinol; 2005 Jun; 17(6):372-8. PubMed ID: 15929742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland.
    Anouar Y; Yon L; Desmoucelles C; Leprince J; Breault L; Gallo-Payet N; Vaudry H
    Endocr Res; 1998; 24(3-4):731-6. PubMed ID: 9888568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells.
    Guillemot J; Aït-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
    Regul Pept; 2006 Nov; 137(1-2):79-88. PubMed ID: 16963134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
    Yon L; Guillemot J; Montero-Hadjadje M; Grumolato L; Leprince J; Lefebvre H; Contesse V; Plouin PF; Vaudry H; Anouar Y
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2579-85. PubMed ID: 12788858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: a comparative study with jerboa.
    Boutahricht M; Guillemot J; Montero-Hadjadje M; Barakat Y; El Ouezzani S; Alaoui A; Yon L; Vaudry H; Anouar Y; Magoul R
    Neurosci Lett; 2007 Mar; 414(3):268-72. PubMed ID: 17240057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
    Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
    J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
    Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
    Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of secretogranin-II (SgII) in the human fetal pituitary: immunocytochemical study using an antiserum raised against a human recombinant SgII.
    Vallet VS; Griffond B; Clavequin MC; de Monti M; Fellmann D; Duval J
    Endocrinology; 1995 May; 136(5):2074-81. PubMed ID: 7720657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands.
    Montero-Hadjadje M; Vaudry H; Turquier V; Leprince J; Do Rego JL; Yon L; Gallo-Payet N; Plouin PF; Anouar Y
    Cell Tissue Res; 2002 Nov; 310(2):223-36. PubMed ID: 12397377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues.
    Leitner B; Fischer-Colbrie R; Scherzer G; Winkler H
    J Neurochem; 1996 Mar; 66(3):1312-7. PubMed ID: 8769899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP stimulates the release of the secretogranin II-derived peptide EM66 from chromaffin cells.
    Guillemot J; Ait-Ali D; Turquier V; Montero-Hadjadje M; Fournier A; Vaudry H; Anouar Y; Yon L
    Ann N Y Acad Sci; 2006 Jul; 1070():309-12. PubMed ID: 16888183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical distribution of EM66 within the hypothalamic parvocellular paraventricular nucleus: colocalization with CRH and TRH but no plasticity related to acute stress and thyroidectomy in the rat.
    El Yamani FZ; Yon L; Guérin M; El Ouezzani S; Alaoui A; Chartrel N; Anouar Y; Magoul R
    Regul Pept; 2013 Mar; 182():28-34. PubMed ID: 23333484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential role for the secretogranin II-derived peptide EM66 in the hypothalamic regulation of feeding behaviour.
    Trebak F; Dubuc I; Arabo A; Alaoui A; Boukhzar L; Maucotel J; Picot M; Cherifi S; Duparc C; Leprince J; Prévost G; Anouar Y; Magoul R; Chartrel N
    J Neuroendocrinol; 2017 Mar; 29(3):. PubMed ID: 28166374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma.
    Guillemot J; Anouar Y; Montero-Hadjadje M; Grouzmann E; Grumolato L; Roshmaninho-Salgado J; Turquier V; Duparc C; Lefebvre H; Plouin PF; Klein M; Muresan M; Chow BK; Vaudry H; Yon L
    Int J Cancer; 2006 Apr; 118(8):2003-12. PubMed ID: 16287097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manserin, a novel peptide from secretogranin II in the neuroendocrine system.
    Yajima A; Ikeda M; Miyazaki K; Maeshima T; Narita N; Narita M
    Neuroreport; 2004 Aug; 15(11):1755-9. PubMed ID: 15257142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C).
    Kirchmair R; Hogue-Angeletti R; Gutierrez J; Fischer-Colbrie R; Winkler H
    Neuroscience; 1993 Mar; 53(2):359-65. PubMed ID: 8492910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secretogranin II-derived peptide secretoneurin stimulates luteinizing hormone secretion from gonadotrophs.
    Zhao E; Basak A; Wong AO; Ko W; Chen A; López GC; Grey CL; Canosa LF; Somoza GM; Chang JP; Trudeau VL
    Endocrinology; 2009 May; 150(5):2273-82. PubMed ID: 19106223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues.
    Schmid KW; Kunk B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
    Histochem J; 1995 Jun; 27(6):473-81. PubMed ID: 7558897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.